The Department of Science and Technology (DST), Government of India will work jointly with Dr. Reddy’s Laboratories Ltd, University of Hyderabad (UoH) and Dr. Reddy’s Institute of Life Sciences (DRILS) for discovery and development of anti-psoriatic drugs. The DST and DRL sponsored project will work on 12-R-Lipoxygenase as target for the discovery and development of drugs for psoriasis.
The project cost is estimated at Rs 190 lakh. The psoriasis and other skin disorders market is currently about $6-7 billion and expected to be reach $13 billion in the next 10 years. In the long term, it is proposed to establish a national R&D facility to work on inflammatory disorders.
Technology offer
Interested in this technology?
Request further information or explore potential cooperation with the technology provider.
Technology request
Can you help meet this technology need?
Share a relevant technology, expertise or partnership opportunity with APCTT.